Home » Newsletters » BioWorld Asia

BioWorld Asia

Nov. 11, 1998

View Archived Issues

Flamels Genvir For Herpes Shows Strong Phase III Data

Stanford Rook Changes Name, Starts Cancer Drugs Phase III

Biomira, Plant Vaccine Firm Partner For Cancer Compounds

Adult Tooth Replacement By Gene Expression Could Be Wave Of Dental Future

Agis Buys Stake In Pharmos, Becomes Largest Shareholder

Trinity Biotech Earnings Up; HIV Test Marketing Expands

U.K. Officials, Insurers Join To Validate Genetic Testing

Phytopharm, Heska Sign Deal Covering Botanical Pet Drugs

Treatment Of Blood Clots Explored By Two Groups

Cambridge Antibodys RA Drug Proving Effective In Early Data

Other News To Note

BioVision Aims To Bridge Japanese, U.S. Biotech

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...